Serum creatinine elevation after switch to dolutegravir in a human immunodeficiency virus-positive kidney transplant recipient

Dolutegravir is a preferred antiretroviral drug for human immunodeficiency virus (HIV)-infected patients following solid organ transplantation. It has potent antiretroviral activity and does not interact with calcineurin inhibitors. We describe a case of an HIV-infected kidney transplant patient, wh...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Transpl Infect Dis
Asıl Yazarlar: Lee, D.H., Malat, G.E., Bias, T.E., Harhay, M.N., Ranganna, K., Doyle, A.M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2016
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5525135/
https://ncbi.nlm.nih.gov/pubmed/27159656
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tid.12545
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller